Christopher Ryan


  • 4605 Citations
  • 37 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
docetaxel Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Androgens Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2016

Blood Vessels

Research Output 1998 2019

  • 4605 Citations
  • 37 h-Index
  • 89 Article
  • 1 Chapter
  • 1 Review article
1 Citation (Scopus)

Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Patel, S., von Mehren, M., Reed, D. R., Kaiser, P., Charlson, J., Ryan, C., Rushing, D., Livingston, M., Singh, A., Seth, R., Forscher, C., D'Amato, G., Chawla, S. P., McCarthy, S., Wang, G., Parekh, T., Knoblauch, R., Hensley, M. L., Maki, R. G. & Demetri, G. D., Aug 1 2019, In : Cancer. 125, 15, p. 2610-2620 11 p.

Research output: Contribution to journalArticle

Open Access
5 Citations (Scopus)

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

Tap, W. D., Gelderblom, H., Palmerini, E., Desai, J., Bauer, S., Blay, J. Y., Alcindor, T., Ganjoo, K., Martín-Broto, J., Ryan, C., Thomas, D. M., Peterfy, C., Healey, J. H., van de Sande, M., Gelhorn, H. L., Shuster, D. E., Wang, Q., Yver, A., Hsu, H. H., Lin, P. S. & 3 others, Tong-Starksen, S., Stacchiotti, S. & Wagner, A. J., Aug 10 2019, In : The Lancet. 394, 10197, p. 478-487 10 p.

Research output: Contribution to journalArticle

Macrophage Colony-Stimulating Factor
Giant Cell Tumor of Tendon Sheath
Clinical Trials Data Monitoring Committees
Colony-Stimulating Factor Receptors
7 Citations (Scopus)

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma

Davis, L., Bolejack, V., Ryan, C., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jun 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 16, p. 1424-1431 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Clinical Trials Data Monitoring Committees
18 Citations (Scopus)

Adjuvant Vascular Endothelial Growth Factor–targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis

Sun, M., Marconi, L., Eisen, T., Escudier, B., Giles, R. H., Haas, N. B., Harshman, L. C., Quinn, D. I., Larkin, J., Pal, S. K., Powles, T., Ryan, C., Sternberg, C. N., Uzzo, R., Choueiri, T. K. & Bex, A., Jan 1 2018, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Blood Vessels
Vascular Endothelial Growth Factor Receptor
Disease-Free Survival

ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas

Lu, E. & Ryan, C., Jan 1 2018, (Accepted/In press) In : Annals of Surgical Oncology.

Research output: Contribution to journalArticle